SkinMedica invest in cosmeceuticals

SkinMedica - a specialty pharmaceutical company - is to receive
financing to further expand its cosmeceutical pipeline. The company
has entered a deal with existing, and new investors to sell $25.8
million of its Series D preferred shares.

"This financing exhibits the extremely high caliber of investors that SkinMedica has been able to attract and their belief in the potential for both our pharmaceutical and cosmeceutical product lines. We anticipate that the funding from this round will enable us to expand our pipeline and sustain the growth of our current products,"​ said CEO of SkinMedica Rex Bright.

Funding will be used to expand the pipeline of pharmaceutical and cosmeceutical products and to fund business development activities including possible acquisitions of dermatological products and technologies.

SkinMedica​, which develops and commercialises dermatology products, currently markets a line of cosmeceutical products including TNS Recovery Complex - with antioxidants, matrix proteins and soluble collagens - to reduce the signs of aging.

"SkinMedica's business model is sound and takes advantage of two highly desirable and growing markets in dermatology, pharmaceuticals and cosmeceuticals,"​ said newly appointed MD Andrew Schiff.

US cosmeceutical sales reached $3.4 billion in 2002, according to market research company Freedonia Group, this is only a tiny fraction of the $185.2 billion US pharmaceutical market.

Related topics Business & Financial Skin Care

Related news

Show more

Related products

show more

Calendula Cellular Elixir: Alchemy in a cell

Calendula Cellular Elixir: Alchemy in a cell

Content provided by Naolys | 24-Apr-2024 | Product Brochure

Get ready to experience a cellular evolution in skincare with InnerLift Calendula's advanced Plant Cell biotechnology.

See our latest innovations in personal care

See our latest innovations in personal care

Content provided by Covation Bio™ PDO | 02-Apr-2024 | White Paper

At CovationBio PDO, we’re helping the world achieve its sustainability goals by enabling better performing, better-for-the planet products across a range...

Collagen Reimagined, Discover Biodesigned Type XXI

Collagen Reimagined, Discover Biodesigned Type XXI

Content provided by Geltor | 20-Mar-2024 | Product Brochure

Collagen is the body’s most abundant protein and a mainstream ingredient for beauty. Type XXI collagen transcends a common protein into a powerful bioactive

Empowering natural barrier function for future-proof skin

Empowering natural barrier function for future-proof skin

Content provided by Lucas Meyer Cosmetics | 14-Mar-2024 | White Paper

Corneopeptyl™ is a new patented peptide biomimetic to the LCE6A protein, obtained by green chemistry-based synthesis. By mimicking the LCE6A protein activity,...

Related suppliers

Follow us

Products

View more

Webinars

Podcast

Beauty 4.0 Podcast